by cristiano | Oct 17, 2018
Cutaneous allergometric tests, if possible, should be preferred and considered as the first diagnostic level in case of patients with clinical history of suspect allergic reactions, as they are more rapid, less invasive and cheaper than serological tests. Exceptions...
by cristiano | Oct 17, 2018
In absence of clinical history of signs/symptoms of suspect hypersensitivity reaction (i.e.: urticaria or other typical muco-cutaneous manifestations, angioedema, hypotension, dyspnoea, simultaneous involvement of two or more organs/apparatus…) allergometric...
by cristiano | Oct 17, 2018
Although the first line of intervention in Parkinson’s disease is pharmacological, recent evidence has shown that multidisciplinary therapy using non-drug approaches can improve the symptoms of the disease or even slow its progression. These include regular...
by cristiano | Oct 17, 2018
According to recent evidence, therapy with anti-Parkinsonian drugs is inappropriately discontinued or modified in a large percentage (up to 75%) of patients with Parkinson’s disease who are admitted to emergency or non-neurological hospital wards. This is one of...
by cristiano | Oct 17, 2018
Levodopa prescription as a drug treatment in Parkinson’s disease is often delayed in favour of other drug categories (such as dopamine agonists) due to concerns about the risk of drug-induced motor complications or levodopa toxicity. However, recent evidence has...
Recent Comments